Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03427879 · ClinicalTrials.gov registry record · Phase 1
Effect of Flavonoids on Gut Permeability in Cyclists
A Phase 1 study, sponsored by Utah State University.
- Completed
- Registry status
- Phase 1
- Development phase
- 12
- Enrollment target
NCT03427879 is a Phase 1 study that has completed, run by Utah State University. The registered enrollment target is 12 participants.
The verdict
NCT03427879, a Phase 1 study, has completed, sponsored by Utah State University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 12 participants
- Enrollment target
Study Summary
The purpose of this investigation is to test the hypothesis that chronic supplementation with a dairy-based beverage containing a mixture of blueberry, green tea, and cocoa flavonoids (non-nutritive natural plant compounds) will ameliorate exercise-related changes in gut permeability and inflammation. In a previous feeding study in humans, (NCT02728570) a high flavonoid diet (flavonoids at 340 mg/1000kcal) was effective in mitigating gut permeability and inflammation in overweight and obese adults compared to a low flavonoid diet (10mg/1000 kcal). To test this hypothesis, 20 trained cyclists will complete a randomized crossover study with supplementation for 2 weeks with a dairy-based sports beverage containing either a high flavonoid (approximately 620 mg) or low flavonoid (approximately 5mg) beverage. After the two week intervention, cyclists will complete a 1 hour cycling trial (45 min at 65% VO2 max then 15 minute time trial). The primary endpoints will be gut permeability as measured by plasma intestinal fatty acid binding protein (I-FABP) and the differential sugar test. Secondary endpoints will include gut inflammation (measured via fecal calprotectin), plasma cytokines (IL-6, IL-10 and TNFα) and plasma LPS. In addition, the distance completed in the time trial is a secondary endpoint.
Interventions
- DRUG Low flavonoid beverage
- DRUG High flavonoid beverage
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2018-09-14 |
| Est. Completion | 2019-07-31 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03427879
The ClinicalTrials.gov registry entry for NCT03427879 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Utah State University, which has 27 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Low flavonoid beverage is the first listed.
NCT03427879 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03427879 about?
NCT03427879 is a clinical study titled "Effect of Flavonoids on Gut Permeability in Cyclists". The purpose of this investigation is to test the hypothesis that chronic supplementation with a dairy-based beverage containing a mixture of blueberry, green tea, and cocoa flavonoids (non-nutritive natural plant compounds) will ameliorate exercise-related changes in gut permeability and inflammatio...
What is the current status of trial NCT03427879?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 12 participants. The study started on 2018-09-14. Estimated completion is 2019-07-31.
What interventions are being tested in trial NCT03427879?
The interventions under investigation include: Low flavonoid beverage (DRUG), High flavonoid beverage (DRUG).
Who is sponsoring clinical trial NCT03427879?
This trial is sponsored by Utah State University, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.